The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients

Key facts

Sponsor

Tulane University

Principal Investigator

Jacques Courseault, MD

Tulane University

Intervention

Dextrose 50% Intravenous Solution(drug)

Enrollment

40 enrolled

Eligibility

18-75 years · All sexes

Timeline

2026 – 2027

Study locations (1)

• Tulane Hospital and Clinics, New Orleans, Louisiana, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Ehlers-Danlos syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT05561270
  Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome
  New York Institute of Technology
• ACTIVE NOT RECRUITINGPHASE4NCT05603741
  Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
  University of Calgary
• ACTIVE NOT RECRUITINGNANCT04036305
  Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
  Vanderbilt University Medical Center
• ACTIVE NOT RECRUITINGEARLY PHASE1NCT03686748
  Two Point Discrimination
  Children's Hospital Medical Center, Cincinnati
• ACTIVE NOT RECRUITINGNCT05976841
  SEDVasc (RaDiCo Cohort) (RaDiCo-SEDVasc)
  Institut National de la Santé Et de la Recherche Médicale, France
• RECRUITINGNCT04133272
  Registry of Ehlers-Danlos Syndrome
  Luca Sangiorgi

See all trials for Ehlers-Danlos syndrome →